Shrishti Biopharm Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Shrishti Biopharm
Shrishti Biopharm Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2021 (Three years and four months 17 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sadayan Murugesan and Anbalagan Rajapathar serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239TN2021PTC146488
-
Company No.
146488
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Sep 2021
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Shrishti Biopharm?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sadayan Murugesan
|
Whole-Time Director | 25-Sep-2021 | Current |
|
Anbalagan Rajapathar
|
Whole-Time Director | 25-Sep-2021 | Current |
Financial Performance of Shrishti Biopharm.
Enhance accessibility to Shrishti Biopharm's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shrishti Biopharm?
Unlock access to Shrishti Biopharm's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Shrishti Power Technologies Private LimitedSadayan Murugesan and Anbalagan Rajapathar are mutual person
-
Aran Hse Products Private LimitedSadayan Murugesan and Anbalagan Rajapathar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shrishti Biopharm?
Shrishti Biopharm has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shrishti Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrishti Biopharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.